Home | News | Directories | Calendar | Maps | Contact Us | Webmail
Perelman School of Medicine at the University of Pennsylvania Advanced Search

Valerianna K. Amorosa, M.D.

Valerianna K. Amorosa, M.D.

faculty photo
Associate Professor of Clinical Medicine
Department: Medicine

Contact information
Philadelphia Veteran's Administration Medical Center,
Department of Medicine
Philadelphia, PA 19104
Office: 215-823-5800
Education:
B.A. (Molecular Biology Cum Laude)
Princeton University, 1993.
M.D.
Washington University in St. Louis, 1998.
Permanent link
 
Perelman School of Medicine > Faculty > Search

Description of Research Expertise

Clinical research in HIV, HCV coinfection

Description of Clinical Expertise

HIV, HIV/HCV coinfection

Selected Publications

Gowda C, Compher C, Amorosa VK, Lo Re V 3rd: Association between chronic hepatitis C virus infection and low muscle mass in US adults J Viral Hepat Page: 12273, July 2014.

Cho H, Kikuchi M, Li Y, Nakamoto N, Amorosa V, Valiga ME, Chang KM: Induction of Multiple Immune Regulatory Pathways with Differential Impact in HCV/HIV Coinfection. Front Immunol 5(265): 265, Jul 2014.

Shah NN, Harrison N, Stonecypher M, Frank D, Amorosa V, Svoboda J: Extracavitary Primary Effusion Lymphoma Initially Presenting With Hemophagocytic Lymphohistocytosis. Clin Lymphoma Myeloma Leuk Page: e157-60, June 2014.

Nagler AR, Kim BS, Gormley RH, Chandler LJ, Han JH, Amorosa VK, Kovarik CL: Verrucous nodule on the upper lip. Cutis 93(2): E15-7, Feb 2014.

Hafkin JS, Osborn MK, Localio AR, Amorosa VK, Kostman JR, Stern JJ, De La Torre P, Mounzer K, Frank I, Gross R, Chang KM, Lo Re V 3rd: Incidence and risk factors for incomplete HBV DNA suppression in HIV/HBV-co-infected patients initiating tenofovir-based therapy J Viral Hepat 21(4): 288-96, 2014.

Amorosa VK, Luetkemeyer A, Kang M, Johnson VA, Umbleja T, Haas DW, Yesmin S, Bardin MC, Chung RT, Alston-Smith B, Tebas P, Peters MG: Addition of nitazoxanide to PEG-IFN and ribavirin to improve HCV treatment response in HIV-1 and HCV genotype 1 coinfected persons naïve to HCV therapy: results of the ACTG A5269 trial. HIV clinical trials 14(6): 274-83, Nov-Dec 2013.

Sulkowski MS, Kang M, Matining R, Wyles D, Johnson VA, Morse GD, Amorosa VK, Bhattacharya D, Coughlin K, Wong-Staal F, Glesby MJ: Safety and Antiviral Activity of the HCV Entry Inhibitor ITX5061 in Treatment-Naive HCV-Infected Adults: A Randomized, Double-Blind, Phase 1b Study. J Infect Dis Oct 2013.

Amorosa VK, Aibana O, Shire N, Dorey-Stein Z, Ferrara T, Gilmore J, Kostman J, Lo Re V: Willingness to Undergo a Repeat Liver Biopsy among HIV/Hepatitis C Virus-Coinfected and Hepatitis C Virus-Monoinfected Patients. Journal of Clinical Gastroenterology. (eds.). 47(5): 457-60, May-Jun 2013.

Lee YJ, Osinusi A, M Kang, T Umbleja, Amorosa VK, Kottilil S, Peters MG: Augmentation of Interferon signaling by Nitazoxanide in HIV HCV Coinfected Patients : Exploratory Analysis from the ACTG5269 trial Conference on Retroviruses and Opportunistic Infections Atlanta,GA March 2013.

Gluckman S, Amorosa VK, Dismukes W, Gordon: ABIM Update in Infectious Diseases. ABIM Feb 2013.

back to top
Last updated: 11/14/2014
The Trustees of the University of Pennsylvania